IPO Announced

Agomab Therapeutics NV IPO

US$200m raised

Lodged 5 Feb 2026 · NASDAQ: AGMB · US$16.00 cash per share

Advisers

Agomab Therapeutics NV

Issuer

Legal adviser
Issuer
Agomab Therapeutics NV
Issuer based in
Belgium
Sector
Biotech
Tags
Biotech, Drug Development, Pharma

Similar deals

All biotech deals →

Sources

Suggest a correction

A missing adviser, a wrong role or a different outcome. A link to a public source helps.